The story of Cordio Medical was recently covered by Alex Knapp, for Forbes magazine.
Cordio’s app, HearO, uses state-of-the-art voice recognition, voice analysis software, and machine learning, to detect changes in a patient’s voice. These changes indicate fluid accumulation in the lungs, one of the main problems with patients suffering from congestive heart failure (CHF).
This early identification allows doctors to intervene with medicine and prevent a patient’s condition from deteriorating to a point where hospitalization is needed.
“What’s exciting about this one is its simplicity, its elegance, and that it’s ready to be universally deployed to our heart failure patients,” says William Abraham, a cardiologist at Ohio State University’s Wexner Medical Center.
Over 5 million Americans are diagnosed with CHF.